NCT05631483View on ClinicalTrials.gov

COlombia DAISe FEasibility Exercise

NATerminatedINTERVENTIONAL
Enrollment

2

Participants

Timeline

Start Date

June 14, 2022

Primary Completion Date

April 26, 2023

Study Completion Date

August 2, 2023

Conditions
Stroke, Acute Ischemic
Interventions
DEVICE

DAISe

Use of the DAISe Thrombectomy Device

Trial Locations (1)

Unknown

Angiosur - Unidad Vascular Integral, Itagüí

Sponsors
All Listed Sponsors
lead

MIVI Neuroscience, Inc.

INDUSTRY

NCT05631483 - COlombia DAISe FEasibility Exercise | Biotech Hunter | Biotech Hunter